The manifold actions of the protein inhibitor of activated STAT proteins on the transcriptional activity of mineralocorticoid and glucocorticoid receptors in neural cells

Journal of Molecular Endocrinology

Volumn 32, Issue 3, 2004, Pages 825-841

  Tirard, M ^a   Jasbinsek, J ^a   Almeida, O F X ^a   Michaelidis, T M ^a,b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; COMPLEMENTARY DNA; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; PROTEIN INHIBITOR; STAT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA ISOLATION; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; NERVE CELL; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION; TWO HYBRID SYSTEM; WESTERN BLOTTING;

ALDOSTERONE; CELL LINE, TUMOR; DEXAMETHASONE; GENES, REPORTER; GLUCOCORTICOIDS; HUMANS; NEURONS; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEINS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 3042855343     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0320825     Document Type: Article

References (75)

1. Abdel-Hafiz H, Takimoto GS, Tung L & Horwitz KB 2002 The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression. Journal of Biological Chemistry 277 33950-33956.
2. Almeida OFX, Conde GL, Crochemore C, Demeneix BA, Fischer D, Hassan AH, Meyer M, Holsboer F & Michaelidis TM 2000 Subtle shifts in the ratio between pro and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB Journal 14 779-790.
3. Aravind L & Koonin EV 2000 SAP - a putative DNA-binding motif involved in chromosomal organization. Trends in Biochemical Sciences 25 112-114.
4. Arora T, Liu B, He H, Kim J, Murphy TL, Murphy KM, Modlin RL & Shuai K 2003 PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4. Journal of Biological Chemistry 278 21327-21330.
5. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE & Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 268-275.
6. Chauchereau A, Amazit L, Quesne M, Guiochon-Mantel A & Milgrom E 2003 Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. Journal of Biological Chemistry 278 12335-12343.
7. Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P & Shuai K 1997 Specific inhibition of Stat3 signal transduction by PIAS3. Science 278 1803-1805.
8. David G, Neptune, MA & DePinho RA 2002 SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. Journal of Biological Chemistry 277 23658-23663.
9. DeFranco DB 2002 Navigating steroid hormone receptors through the nuclear compartment. Molecular Endocrinology 16 1449-1455.
10. Derfoul A, Robertson NM, Hall DJ & Litwack G 2000 The N-terminal domain of the mineralocorticoid receptor modulates both mineralocorticoid receptor- and glucocorticoid receptor-mediated transactivation from Na/K ATPase beta1 target gene promoter. Endocrine 13 287-295.
11. Desterro JM, Rodriguez MS & Hay RT 1998 SUMO-1 modification of IkappaB alpha inhibits NF-kappaB activation. Molecular Cell 2 233-239.
12. Girdwood D, Rumpass D, Vaughan OA, Thain A, Anderson LA, Snowden AW, Grarcia-Wilson E, Perkins ND & Hay RT 2003 P300 transcriptional repression is mediated by SUMO modification. Molecular Cell 11 1043-1054.
13. Glass CK & Rosenfeld MG 2000 The coregulator exchange in transcriptional functions of nuclear receptors. Genes and Development 14 121-141.
14. Govindan MV & Warriar N 1998 Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor. Journal of Biological Chemistry 273 24439-24447.
15. Gronemeyer H & Laudet V 2002 The Nuclear Receptor Facts Book. San Diego, CA: Academic Press, 462 pp.
16. Gross M, Liu B, Tan J, French FS, Carey M & Shuai K 2001 Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene 20 3880-3887.
17. 2- and COOH-terminal interaction. Journal of Biological Chemistry 277 25631-25639.
18. Hochstrasser M 2001 SP-RING for SUMO: new functions bloom for a ubiquitin-like protein. Cell 107 5-8.
19. Hollenberg SM, Giguere V, Segui P & Evans RM 1987 Colocalization of DNA binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 49 39-46.
20. Iniguez-Lluhi JA & Pearce D 2000 A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Molecular and Cellular Biology 20 6040-6050.
21. Janne OA, Moilanen AM, Poukka H, Rouleau N, Karvonen U, Kotaja N, Hakli M & Palvimo JJ 2000 Androgen-receptor-interacting nuclear proteins. Biochemical Society Transactions 28 401-405.
22. Jimenez-Lara AM, Heine MJ & Gronemeyer H 2002 PIAS3 (protein inhibitor of activated STAT-3) modulates the transcriptional activation mediated by the nuclear receptor coactivator TIF2. FEBS Letters 526 142-146.
23. Joëls M 2000 Modulatory actions of steroid hormones and neuropeptides on electrical activity in brain. European Journal of Pharmacology 405 207-216.
24. Joëls M 2001 Corticosteroid actions in the hippocampus. Journal of Neuroendocrinology 13 657-669.
25. Junicho A, Matsuda T, Yamamoto T, Kishi H, Korkmaz K, Saatcioglu F, Fuse H & Muraguchi A 2000 Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells. Biochemical and Biophysical Research Communications 278 9-13.
26. Kahyo T, Nishida T & Yasuda H 2001 Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Molecular Cell 8 713-718.
27. Kitagawa H, Yanagisawa J, Fuse H, Ogawa S, Yogiashi Y, Okuno A, Nagasawa H, Nakajima T, Matsumoto T & Kato S 2002 Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex. Molecular and Cellular Biology 22 3698-3706.
28. de Kloet ER, Oitzl MS & Joëls M 1999 Stress and cognition: are corticosteroids good or bad guys? Trends in Neurosciences 22 422-426.
29. de Kloet ER, Vreugdenhil E, Oitzl MS & Joëls M 1998 Brain corticosteroid receptor balance in health and disease. Endocrine Reviews 19 269-301.
30. Kotaja N, Aittomaki S, Silvennoinen O, Palvimo JJ & Janne OA 2000 ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Molecular Endocrinology 14 1986-2000.
31. Kotaja N, Karvonen U, Janne OA & Palvimo JJ 2002a PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Molecular and Cellular Biology 22 5222-5234.
32. Kotaja N, Vihinen M, Palvimo JJ & Janne CA 2002b Androgen receptor-interacting protein 3 and other PIAS proteins cooperate with glucocorticoid receptor-interacting protein 1 in steroid receptor-dependent signaling. Journal of Biological Chemistry 277 17781-17788.
33. Le Drean Y, Mincheneau N, Le Goff P & Michel D 2002 Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology 143 3482-3489.
34. Levy L, Neuveut C, Renard CA, Charneau P, Branchereau S, Gauthier F, Van Nhieu JT, Cherqui D, Petit-Bertron AF, Mathieu D et al. 2002 Transcriptional activation of interleukin-8 by beta-catenin-Tcf4. Journal of Biological Chemistry 277 42386-42393.
35. 2- and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in cytokine-induced PIAS1-Star1 interaction. PNAS 97 5267-5272.
36. Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD & Shuai K 1998 Inhibition of Stat1-mediated gene activation by PIAS1. PNAS 95 10626-10631.
37. Liu B, Gross M, ten Hoeve J & Shuai K 2001 A transcriptional corepressor of Stat1 with an essential LXXLL signature motif. PNAS 98 3203-3207.
38. Liu W, Wang, J, Sauter NK & Pearce D 1995 Steroid receptor heterodimerization demonstrated in vitro and in vivo. PNAS 92 12480-12484.
39. Long J, Matsuura I, He D, Wang G, Shuai K & Liu F 2003 Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT. PNAS 100 9791-9796.
40. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ 1951 Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 277-283.
41. McGaugh JL & Roozendaal B 2002 Role of adrenal stress hormones in forming lasting memories in the brain. Current Opinion in Neurobiology 12 205-210.
42. Megidish T, Xu JH & Xu CW 2001 Activation of p53 by protein inhibitor of activated Stat1 (PIAS1). Journal of Biological Chemistry 277 8255-8259.
43. Meijer OC 2002 Coregulator proteins and corticosteroid action in the brain. Journal of Neuroendocrinology 14 499-505.
44. Metivier R, Penot G, Flouriot G & Pakdel F 2001 Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains. Molecular Endocrinology 15 1953-1970.
45. Muller S, Berger M, Lehembre F, Seeler JS, Haupt Y & Dejean A 2000 c-Jun and p53 activity is modulated by SUMO-1 modification. Journal of Biological Chemistry 275 13321-13329.
46. Muller S, Hoege C, Pyrowolakis G & Jentsch S 2001 SUMO, ubiquitin's mysterious cousin. Nature Reviews. Molecular and Cellular Biology 2 202-210.
47. Nakagawa K & Yokosawa H 2002 PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. FEBS Letters 530 204-208.
48. Nair SM, Werkman TR, Craig J, Finnell R, Joëls M & Eberwine JH 1998 Corticosteroid regulation of ion channel conductances and mRNA levels in individual hippocampal CA1 neurons. Journal of Neuroscience 18 2685-2696.
49. Nishida T & Yasuda H 2002 PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. Journal of Biological Chemistry 277 41311-41317.
50. Pearce D & Yamamoto KR 1993 Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259 1161-1165.
51. Pichler A & Melchior F 2002 Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport. Traffic 3 381-387.
52. Reul JM & de Kloet ER 1985 Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117 2505-2511.
53. Rodel B, Tavassoli K, Karsunky H, Schmidt T, Bachmann M, Schaper F, Heinrich P, Shuai K, Elsasser HP & Moroy T 2000 The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. EMBO Journal 19 5845-5855.
54. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP & Hay RT 1999 SUMO-1 modification activates the transcriptional response of p53. EMBO Journal 18 6455-6461.
55. Rogerson FM & Fuller PJ 2003 Interdomain interactions in the mineralocorticoid receptor. Molecular and Cellular Endocrinology 200 45-55.
56. Roland BL, Krozowski ZS & Funder JW 1995 Glucocorticoid receptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies. Molecular and Cellular Endocrinology 111 R1-R7.
57. Rosenfeld MG & Glass CK 2001 Coregulator codes of transcriptional regulation by nuclear receptors. Journal of Biological Chemistry 276 36865-36868.
58. Rupprecht R, Arriza JL, Spengler D, Reul JM, Evans RM, Holsboer F & Damm K 1993 Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Molecular Endocrinology 7 597-603.
59. Sachdev S, Bruhn L, Sieber H, Pichler A, Melchior F & Grosschedl R 2001 PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes and Development 15 3088-3103.
60. Schmidt D & Muller S 2002 Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. PNAS 99 2872-2877.
61. Sloviter RS, Sollas AL, Dean E & Neubort S 1993 Adrenalectomy-induced granule cell degeneration in the rat hippocampal dentate gyrus: characterization of an in vivo model of controlled neuronal death. Journal of Comparative Neurology 330 324-336.
62. Sousa N & Almeida OFX 2002 Corticosteroids: sculptors of the hippocampal formation. Reviews in the Neurosciences 13 59-84.
63. Tallec PL, Kirsh O, Lecomte M-C, Viengchareun S, Zennaro M-C, Dejean A & Lombes M 2003 Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: Implication of small ubiquitin-related modifier 1 modification. Molecular Endocrinology 17 2529-2542.
64. Tan JA, Hall SH, Hamil KG, Grossman G, Petrusz P, Liao J, Shuai K & French FS 2000 Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis. Molecular Endocrinology 14 14-26.
65. Tan JA, Hall SH, Hamil KG, Grossman G, Petrusz P & French FS 2002 Protein inhibitors of activated STAT resemble scaffold attachment factors and function as interacting nuclear receptor coregulators. Journal of Biological Chemistry 277 16993-17001.
66. Tetel MJ, Giangrande PH, Leonhardt SA, McDonnell DP & Edwards DP 1999 Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Molecular Endocrinology 13 910-924.
67. Thompson J, Saatcioglu F, Janne OA & Palvimo JJ 2001 Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. Molecular Endocrinology 15 923-935.
68. Tian S, Poukka H, Palvimo JJ & Janne OA 2002 Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor. Biochemical Journal 367 907-911.
69. Valdez BC, Henning D, Perlaky L, Busch RK & Busch H 1997 Cloning and characterization of Gu/RH-II binding protein. Biochemical and Biophysical Research Communications 234 335-340.
70. van Steensel B, van Binnendijk EP, Hornsby CD, van der Voort HT, Krozowski ZS, de Kloet ER & van Driel R 1996 Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei of rat hippocampus neurons. Journal of Cell Science 109 787-792.
71. Verger A, Perdomo J & Crossley M 2003 Modification with SUMO. A role in transcriptional regulation. EMBO Reports 4 137-142.
72. Wu L, Wu H, Ma L, Sangiorgi F, Wu N, Bell JR, Lyons GE & Maxson R 1997 Miz1, a novel zinc finger transcription factor that interacts with Msx2 and enhances its affinity for DNA. Mechanisms of Development 65 3-17.
73. Xu J & Li Q 2003 Review of the in vivo functions of the p 160 steroid receptor coactivator family. Molecular Endocrinology 17 1681-1692.
74. + channel (alpha-ENaC) transcription by Ras activation in salivary epithelial cells. Journal of Biological Chemistry 276 29805-29814.
75. Zhou ZX, Lane MV, Kemppainen JA, French FS & Wilson EM 1995 Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Molecular Endocrinology 9 208-218.